Hamdan Al Balushi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Squamous Cell Carcinoma

African American

Top Venues

Current drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Abdullah Al Lawati, Srijit Das
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma. Current drug targets 25 (3) (2024)
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Abdullah Al Lawati, Srijit Das
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma. Current drug targets 25 (3) (2024)
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Abdullah Al Lawati, Srijit Das
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma. Current drug targets 25 (3) (2024)
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Srijit Das, Abdullah Al Lawati
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma. Current drug targets (2023)